行情

OPK

OPK

OPKO Health
NASDAQ

实时行情|Nasdaq Last Sale

2.130
+0.110
+5.45%
盘后: 2.130 0 0.00% 16:00 09/23 EDT
开盘
2.010
昨收
2.020
最高
2.145
最低
2.010
成交量
297.30万
成交额
--
52周最高
4.300
52周最低
1.730
市值
13.11亿
市盈率(TTM)
-5.0510
分时
5日
1月
3月
1年
5年

分析师评级

3位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

OPK 新闻

  • Opko Health up 4% on long-term somatrogon data
  • seekingalpha.46分钟前
  • 观点:负利率不会很快来到美国
  • 新浪美股.47分钟前
  • 黄金期货周一收高1.1% 白银跃升4.8%
  • 新浪美股.55分钟前
  • 美联储研究报告称市场对利率降至零的预期上升
  • 新浪美股.1小时前

更多

所属板块

制药
-0.37%
制药与医学研究
-0.44%

热门股票

名称
价格
涨跌幅

OPK 简况

OPKO Health, Inc. is a healthcare company. Its segments include Pharmaceutical, Diagnostics and Corporate. Pharmaceutical consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain and its pharmaceutical research and development operations. Diagnostics consists of the clinical laboratory operations in Bio-Reference Laboratories (Bio-Reference) and its point-of-care operations. Through Bio-Reference, it operates laboratory divisions, such as Bio-Reference, GenPath (Oncology), GenPath (Women's Health), GeneDx and Laboratorio Bueno Salud. As of December 31, 2016, it had one commercial stage pharmaceutical product and several pharmaceutical compounds and technologies in various stages of research and development for a range of indications and conditions, including Renal Products, Biologics, hGH-CTP, Factor VII, Oxyntomodulin, active pharmaceutical ingredients, Oligonucleotide Therapeutics, NK-1 Program, Asthma and chronic obstructive pulmonary disease.
展开

Webull提供Opko Health Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。